医美定价权近日，童颜针领域接连传出新动态。1月16日，港股上市企业四环医药发布公告称旗下童颜针新增6个规格获国家药监局批准上市。据了解，此次规格拓展前，产品已获批45mg╱瓶、75mg╱瓶、150mg╱瓶三类规格；新增获批的六类规格为60mg╱瓶、80mg╱瓶、100mg╱瓶、110mg╱瓶、120mg╱瓶、130mg╱瓶。四环医药公告表示，新增规格能精准匹配多元抗衰需求，优化临床操作灵活性，强化...
Source Link医美定价权近日，童颜针领域接连传出新动态。1月16日，港股上市企业四环医药发布公告称旗下童颜针新增6个规格获国家药监局批准上市。据了解，此次规格拓展前，产品已获批45mg╱瓶、75mg╱瓶、150mg╱瓶三类规格；新增获批的六类规格为60mg╱瓶、80mg╱瓶、100mg╱瓶、110mg╱瓶、120mg╱瓶、130mg╱瓶。四环医药公告表示，新增规格能精准匹配多元抗衰需求，优化临床操作灵活性，强化...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.